Genmab — September 2020
-
Trispecific antibodies take to the clinic -mentions the Sanofi CD3xCD28xCD38 - https://www.nature.com/articles/d41573-020-00164-3
-
Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta
(ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis https://www.novartis.com/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis -
Genmab begynder at vise svaghedstegn
Kommentarerne til C25-aktierne er primært baseret på teknisk analyse med en tidshorisont på 2-3 uger og ikke dybdegående fundamentalanalyser. Købs- og salgsanbefalingerne er kun vejledende. A. P. Møller – Mærsk A – Hold Aktuel kurs: 8875,00 A. P. Møller – Mærsk A følger stort set selskabets B-aktie, og giver derfor ikke anledning til en selvstændig […]
Økonomisk Ugebrev (ugebrev.dk)
-
Det er blot en kortsigtet teknisk analyse: https://www.proinvestor.com/investornyt/666637/genmab-begynder-at-vise-svaghedstegn
-
Enhver har kunnet se denne udvikling i den seneste tid.
-
Vor
egen tekniske analyse er her: https://www.proinvestor.com/boards/86703/Teknisk-analyse-af-Genmab -
God morgen.
-
Se svar i Twittertråden og følg den løbende: Vincent Rajkumar @VincentRK Question for hem/onc docs: Newly Diagnosed AL Amyloidosis not in VGPR following frontline ASCT (No induction was given before ASCT). What’s your regimen of choice?https://twitter.com/VincentRK/status/1304414797325312001
-
God morgen.
-
Test
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind